XML 36 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2017
Fair Value Disclosures [Abstract]  
Summary of Fair Value and Carrying Value of Assets and Liabilities Measured on Recurring and Non-recurring Basis
The following table includes the estimated fair value and carrying value of those assets and liabilities that are measured at fair value on a recurring and non-recurring basis as well as the estimated fair value of the Company’s financial instruments that are not accounted for at the fair value on a recurring basis.
 
 
 
 
 
June 30, 2017
 
December 31, 2016
 
 
Fair
Value
Hierarchy
Level
 
Carrying
Amount
Asset /
(Liability)
$
 
Fair
Value
Asset /
(Liability)
$
 
Carrying
Amount
Asset /
(Liability)
$
 
Fair
Value
Asset /
(Liability)
$
Recurring:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents and restricted cash
 
Level 1
 
88,635

 
88,635

 
94,907

 
94,907

Derivative instruments (note 7)
 
 
 
 
 
 
 
 
 
 
     Interest rate swap agreements (1)
 
Level 2
 
2,744

 
2,744

 
3,143

 
3,143

     Time-charter swap agreement (1)
 
Level 3
 

 

 
875

 
875

     Stock purchase warrant
 
Level 3
 

 

 
287

 
287

 
 
 
 
 
 
 
 
 
 
 
Non-Recurring:
 
 
 
 
 
 
 
 
 
 
Investment in TIL (note 5b)
 
Level 1
 
19,266

 
19,266

 
 
 
 
Vessels held for sale (note 12)
 
Level 2
 

 

 
33,802

 
33,802

 
 
 
 
 
 
 
 
 
 
 
Other:
 
 
 
 
 
 
 
 
 
 
Advances to equity accounted investments
 
Note (2)
 
9,930

 
 Note (2)

 
10,480

 
 Note (2)

Long-term debt, including current portion
 
Level 2
 
(821,786
)
 
(810,220
)
 
(933,016
)
 
(923,306
)
 
(1)
The fair value of the Company’s interest rate swap agreements, time-charter swap agreement and forward freight agreements at June 30, 2017 excludes accrued interest expense which is recorded in accrued liabilities on the unaudited consolidated balance sheets.
(2)
The advances to equity accounted investments together with the Company’s investments in the equity accounted investments form the net aggregate carrying value of the Company’s interests in the equity accounted investments in these consolidated financial statements. The fair values of the individual components of such aggregate interests as at June 30, 2017 and December 31, 2016 were not determinable.
Summary of Derivative Instrument Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs
Changes in fair value during the three and six months ended June 30, 2017 and 2016 for the TIL stock purchase warrant, which is measured at fair value on a recurring basis using significant unobservable inputs (Level 3), are as follows:
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30, 2017
 
June 30, 2016
 
June 30, 2017
 
June 30, 2016
 
 
$
 
$
 
$
 
$
Fair value at the beginning of the period
 
166

 
3,053

 
287

 
5,164

Unrealized loss included in earnings
 
(166
)
 
(2,137
)
 
(287
)
 
(4,248
)
Fair value at the end of the period
 

 
916

 

 
916

Changes in fair value during the three and six months ended June 30, 2017 and 2016 for the Company’s time-charter swap agreement, which is described below and is measured at fair value on the recurring basis using significant unobservable inputs (Level 3), are as follows:

 
Three Months Ended
 
Six Months Ended

 
June 30, 2017
 
June 30, 2016
 
June 30, 2017
 
June 30, 2016
 
 
$
 
 
 
 
 
$
Fair value asset - beginning of the period
 
402
 
 
875
 
Settlements
 
(360)
 
(126)
 
(1,106)
 
(126)
Realized and unrealized (loss) gain in earnings
 
(42)
 
1,471
 
231
 
1,471
Fair value asset - at the end of the period
 
 
1,345
 
 
1,345
Summary of Financing Receivables
The following table contains a summary of the Company’s financing receivables by type and the method by which the Company monitors the credit quality of its financing receivables on a quarterly basis.
 
 
 
 
June 30, 2017
 
December 31, 2016
Class of Financing Receivable
Credit Quality Indicator
 
Grade
$
 
$
Advances to equity accounted investments
Other internal metrics
 
Performing
9,930

 
10,480

Total
 
 
 
9,930

 
10,480